FFG
UBX

Ford Financial Group’s Unity Biotechnology UBX Stock Holding History

Ford Financial Group’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-50
Closed – – 481
2021
Q4 		$0 Buy
+50
New +$1.09K ﹤0.01% 533
2021
Q3 		– Sell
-50
Closed -$2K – 519
2021
Q2 		$2K Buy
+50
New +$2.41K ﹤0.01% 482

Other funds holding UBX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return

Ford Financial Group's UBX Position: Q1 2022 in Review

Ford Financial Group sold out of Unity Biotechnology (UBX) in Q1 2022, closing a stake of 50 shares.

Ford Financial Group first reported a position in UBX in Q2 2021 and held it in 2 quarters. The position peaked at $2K in Q2 2021. 70 funds tracked by Wall St. Rank hold UBX as of Q1 2022.

  • Ford Financial Group reported no remaining Unity Biotechnology position as of Q1 2022 after selling out during the quarter.
  • Ford Financial Group sold 50 Unity Biotechnology shares in Q1 2022.
  • Ford Financial Group first reported a position in Unity Biotechnology in Q2 2021 and held it in 2 quarters.
  • Ford Financial Group's Unity Biotechnology position peaked at $2K in Q2 2021.
  • 70 funds tracked by Wall St. Rank held Unity Biotechnology as of Q1 2022.

Based on Ford Financial Group's 13F filing for Q1 2022, filed 13 Apr 2022.